Claudia is a biologist, specialized in toxicology, with more than 25 years of experience in the field non clinical drug development. This includes 10 years in an Italian toxicology contract research organization (CRO) and 17 years in industrial drug development. Since 2003 she is at the working at one of the Italian affiliates of Merck KGaA, Darmstadt, Germany where she is serving as the nonclinical safety representative for different early or late development projects.
Nada Abla Geiser is a Senior DMPK scientist at Medicines for Malaria Venture (MMV). Pharmacist by training, she obtained a PhD in pharmaceutical sciences from the University of Geneva in 2005, and completed a postdoctoral training in pharmacogenetics at the University of California San Francisco. She joined MMV in 2014 from Merck Serono SA (Geneva), an affiliate of Merck KGaA, Darmstadt, Germany, where she worked for six years as laboratory head in charge of in vitro metabolism assays and representing the DMPK function in discovery and development project teams.